Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $170.00 price target on GeneDx (NASDAQ: WGS).The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE